Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dry Eye and Ocular Surface Treatment on Corneal Astigmatism Measurements
NCT07657858Recruiting
- Sponsor
- Jinyang Pharm
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label trial of Aili in dry eye disease (DED) (2 cohorts), sponsored by Jinyang Pharm. Primary endpoints: Interdevice Agreement of Corneal Astigmatism Measurements at 2 weeks and Test-Retest Repeatability of Corneal Astigmatism Measurements at 2 weeks. Started Jan 2026; status: recruiting.
02
Drugs
Aili
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07657858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657858.